-
Making Health Care Safer in Ambulatory Care Settings and Long-term Care Facilities (R18)
(PA-21-267)
Agency for Healthcare Research and Quality
Application Receipt Date(s): Standard dates apply. The first standard due date for the FOA is January 25, 2022.
All applications are due by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)
(PA-21-345)
Office of the Director, NIH
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of General Medical Sciences
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Library of Medicine
National Institute of Mental Health
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
National Center for Environmental Health
National Center for Injury Prevention and Control
National Institute for Occupational Safety and Health
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): Applications are accepted on a rolling basis at any time starting 30 days after the Open Date until the expiration date, unless otherwise noted in Institute specific language. Please consult with Scientific contacts listed in Section VII.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Emerging Global Leader Award (K43 Independent Clinical Trial Required)
(PAR-21-251)
John E. Fogarty International Center
National Institute on Aging
National Cancer Institute
National Institute of Environmental Health Sciences
National Human Genome Research Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Research on Women's Health
Application Receipt Date(s): November 3, 2021, November 3, 2022, and November 3, 2023 by 5:00 PM local time of the applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
(PAR-21-252)
John E. Fogarty International Center
National Institute on Aging
National Cancer Institute
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Research on Women's Health
Application Receipt Date(s): November 3, 2021, November 3, 2022, and November 3, 2023 by 5:00 PM local time of the applicant organization. Alltypes of non-AIDS applicationsallowed for this funding opportunity announcement are due on these dates.
-
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required)
(PAR-21-299)
National Cancer Institute
Application Receipt Date(s): Standard dates apply.
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed)
(PAR-21-300)
National Cancer Institute
Application Receipt Date(s): Standard dates apply.
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)
(PAR-21-301)
National Cancer Institute
Application Receipt Date(s): Standard dates apply.
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)
(PAR-21-302)
National Cancer Institute
Application Receipt Date(s): Standard dates apply.
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
(PAR-21-327)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
(PAR-21-328)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
(PAR-21-330)
National Cancer Institute
Application Receipt Date(s): October 11, 2024
-
AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
(PAS-21-270)
National Institute on Drug Abuse
Application Receipt Date(s): Multiple dates, see announcement.
-
Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R01 - Clinical Trial Optional)
(RFA-DA-22-028)
National Institute on Drug Abuse
Application Receipt Date(s): February 9, 2022
-
Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R21 - Clinical Trial Optional)
(RFA-DA-22-039)
National Institute on Drug Abuse
Application Receipt Date(s): February 9, 2022
-
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
(RFA-DA-22-040)
National Institute on Drug Abuse
Application Receipt Date(s): August 1, 2024
-
An Intergenerational Precision Medicine Research Program for the Study of Factor VIII Immunogenicity in Severe Hemophilia A: Hemophilia A Analytical Cohort Research Program (UG3/UH3 Clinical Trial Not Allowed)
(RFA-HL-22-004)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): October 19, 2021
-
Detecting Cognitive Impairment, Including Dementia, in Primary Care and Other Everyday Clinical Settings for the General Public and Health Equity, Pragmatic Clinical Trials (U01 Clinical Trial Required)
(RFA-NS-22-009)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): November 10, 2021
-
Small Vessel VCID Biomarkers Validation Consortium Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-NS-22-017)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): November 12, 2021
-
The Human BioMolecular Atlas Program (HuBMAP) Demonstration Project (U01 Clinical Trial Not Allowed)
(RFA-RM-21-027)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): November 19, 2021